Anti-CD2 Antibody (Siplizumab)
Catalog No.
F1358
Anti-CD2 Antibody (Siplizumab)
Featured Products
Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody against CD2. Siplizumab depletes T cells, reduces T cell activation, inhibits T cell proliferation, and enriches for naïve and bona fide regulatory T cells.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
288392-69-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
TCD 601, TCD601, MEDI-507
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P06729
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
CD2
Please avoid freeze-thaw cycles.